New target identified to stop the spread of breast cancer

	Tweet

A new potential target to slow breast cancer tumor progression and metastasis has been identified by a team of researchers led by Dr. Richard Kremer from the Research Institute of the McGill University Health Centre (RI-MUHC). Complications in breast cancer patients are commonly caused by the spread of the disease through metastasis to other parts of the body, most often to the bones and lungs. These findings, published this week in the Journal of Clinical Investigation (JCI), suggest that a specific protein plays a key role in the progression of the disease outside of the initial tumor area.

Researchers showed that this particular target called parathyroid hormone-related protein (PTHrP), present at high levels in cancers, is involved in key stages of breast cancer initiation, progression and metastatic spread. “We are hoping for a significant effect on the prevention of breast cancer recurrence, growth and development by using a strategy to decrease the production of that particular protein,” says Dr. Richard Kremer, co-director of the Musculoskeletal Axis of the RI-MUHC and a professor in the Department of Medicine at McGill University.

To better understand the role of PTHrP in cancer development, researchers eliminated the production of the hormone from breast cells using a strategy called “conditional knockout” and then studied the progression of the tumor. “The results showed that without the presence of PTHrP in the breast, even before the tumor developed, a reduction of 80 to 90 per cent in the growth of the tumor was observed,” explains Dr. Kremer. “The removal of this hormone in the breast and breast tumors block not only the growth of the tumors but also its spread to different organs.”

In order to bring this strategy one step closer to the patient, Dr. Kremer and his team developed a monoclonal antibody against PTHrP – a molecule that mimics the antibodies produced as part of the immune system’s response to invaders, which is widely used in cancer treatment. Researchers were able to stop the growth of human breast tumors implanted in animal models and their metastatic spread, paving the way for clinical trials in the near future.

“This opens the door to treatment of patients with a more aggressive type of breast cancer who are not responsive to standard treatment,” says Dr. Kremer. “I see a potential for better treatment of the disease and improvement in quality of life for a very significant number of patients.”

###

Julie Robert
julie.robert@muhc.mcgill.ca
514-934-1934 x71381
McGill University Health Centre

RELATED STORIES:
Gene fuelled transporter causes breast cancer cells to self-destruct   Brisk walkers have lower breast cancer risk   Full Field Digital Mammography: A New Breast Cancer Screening Tool   Researchers Identify Gene That Regulates Breast Cancer Metastasis   Eisai says drug active in advanced breast cancer   IMRT reduces risk of side effects in breast cancer patients   Future Hope for Patients with Breast Cancers Resistant to Tamoxifen   10 Years of Providing Support, Information and Hope to Young Women Diagnosed with Breast Cancer   Roche to file T-DM1 breast cancer drug on good data   Lasers Illuminate Women’s Health in inaugural open-access journal Biomedical Optics Express   Breast cancer cases to climb in China, study   Blacks only face survival gap with some cancers   DCIS patients who get invasive breast cancer have higher mortality   Obesity linked with poorer breast cancer outcomes   Antidepressant doesn’t raise breast cancer risk   Linchpin Gene May Be Useful Target For Breast Cancer Therapies   Breast cancer risk higher in young smokers   Dietary Cadmium May Be Linked with Breast Cancer Risk   Birth size is a marker of susceptibility to breast cancer later in life   The protein TXNL2 provides human breast cancer cells with protection   Breast cancer surgery decisions difficult for many   Analysis of breast-cancer gene role offers promising target

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]